Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...

Thainakarin Hospital has announced its readiness to provide services at the Thainakarin Precision Oncology Center (TPOC), one of Thailand's most advanced health promotion and cancer treatment centers, ...

The University of Barcelona has participated in an international study that has found new evidence linking traumatic experiences and stressful events with endometriosis, a chronic systemic ...

The Texas A&M University System Board of Regents has approved the establishment of the Center for Comparative Genomics in animal genetics.

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Synthetic biologists from Yale were able to re-write the genetic code of an organism—a novel genomically recoded organism (GRO) with one stop codon—using a cellular platform that they developed ...

February is American Heart Month, which is an appropriate time to learn how genetic testing can protect your family.

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

Electrical stimulation of the spinal cord strengthened the muscles of three people with spinal muscular atrophy, a rare motor neuron disease.

Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.